TY - JOUR
T1 - Challenging dogmas :
T2 - Intravenous versus oral beta-lactam antibiotic provocation tests
AU - Molina-Molina, Gustavo-Jorge
AU - Gómez-Duque, Manuel
AU - Agusti Escasany, M. Antonieta
AU - Labrador Horrillo, Moises
AU - Luengo Sánchez, Olga
AU - Sala-Cunill, Anna
AU - Galvan-Blasco, Paula
AU - Guilarte, Mar
AU - Cardona, Victoria
N1 - © 2024 The Authors.
PY - 2024/6
Y1 - 2024/6
N2 - Background: Drug provocation tests (DPT) are considered the gold standard procedure to ascertain the diagnosis of beta-lactam (BL) allergy. Regarding route of administration, current recommendations prioritize oral challenges, considering them safer, and reserving the intravenous route for drugs for which this is the only formulation. Objective: To compare in terms of tolerance and safety two protocols of BL DPT, using an oral protocol (OR-DPT) and an intravenous protocol (IV-DPT). Methods: A descriptive, retrospective study was performed, including adult patients who underwent IV-DPT or OR-DPT for suspected immediate or delayed hypersensitivity to BL antibiotics, over a period of 4 years (between January 2018 and December 2021). Demographical data, index hypersensivity reactions’ characteristics and tolerance to DPT were reviewed. Results: A total of 1036 patients underwent DPT, mean age of 56.8 (standard deviation, SD, 17.8) years, 655 were women (63.2%). Immediate drug hypersensitivity reactions (DHR) had occurred in 564 of patients (54.4%). OR-DPT were performed in 439 (42.4%) and IV-DPT in 597 (57.6%). The frequency of reactions during DPT, regardless of the route used, was low (3.6%): only 16 (3.6%) in OR-DPT and 21 (3.5%) in IV-DPT. From IV-DPT, 16 out 21 DHR during DPT were immediate compared with 4 out of 16 in OR-DPT. Adjusted relative risk of developing a hypersensitivity reaction during IV-DPT versus OR-DPT was 1.13 (95% confidence interval (CI)0.57–2.22). Conclusion: The results suggest that OR-DPT and IV-DPT are both safe procedures when adequately performed. However, IV-DPT protocols showed a higher rate of immediate DHR during DPT probably due to the selection of basal high-risk patients to undergo IV-DPT. In conclusion, IV-DPT may be considered as an option for challenges in drug-allergy studies, entailing a precise administration.
AB - Background: Drug provocation tests (DPT) are considered the gold standard procedure to ascertain the diagnosis of beta-lactam (BL) allergy. Regarding route of administration, current recommendations prioritize oral challenges, considering them safer, and reserving the intravenous route for drugs for which this is the only formulation. Objective: To compare in terms of tolerance and safety two protocols of BL DPT, using an oral protocol (OR-DPT) and an intravenous protocol (IV-DPT). Methods: A descriptive, retrospective study was performed, including adult patients who underwent IV-DPT or OR-DPT for suspected immediate or delayed hypersensitivity to BL antibiotics, over a period of 4 years (between January 2018 and December 2021). Demographical data, index hypersensivity reactions’ characteristics and tolerance to DPT were reviewed. Results: A total of 1036 patients underwent DPT, mean age of 56.8 (standard deviation, SD, 17.8) years, 655 were women (63.2%). Immediate drug hypersensitivity reactions (DHR) had occurred in 564 of patients (54.4%). OR-DPT were performed in 439 (42.4%) and IV-DPT in 597 (57.6%). The frequency of reactions during DPT, regardless of the route used, was low (3.6%): only 16 (3.6%) in OR-DPT and 21 (3.5%) in IV-DPT. From IV-DPT, 16 out 21 DHR during DPT were immediate compared with 4 out of 16 in OR-DPT. Adjusted relative risk of developing a hypersensitivity reaction during IV-DPT versus OR-DPT was 1.13 (95% confidence interval (CI)0.57–2.22). Conclusion: The results suggest that OR-DPT and IV-DPT are both safe procedures when adequately performed. However, IV-DPT protocols showed a higher rate of immediate DHR during DPT probably due to the selection of basal high-risk patients to undergo IV-DPT. In conclusion, IV-DPT may be considered as an option for challenges in drug-allergy studies, entailing a precise administration.
KW - Drug provocation test
KW - Beta-lactam
KW - Intravenous drug provocation test
KW - Oral drug provocation test
KW - Drug hypersensitivity reaction
KW - Beta-lactam
KW - Drug hypersensitivity reaction
KW - Drug provocation test
KW - Intravenous drug provocation test
KW - Oral drug provocation test
UR - http://www.scopus.com/inward/record.url?scp=85193837787&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/a7b8709e-be37-35e0-b7f6-7d915f7813d4/
UR - https://portalrecerca.uab.cat/en/publications/085a8135-3d5d-4879-8750-42323bf8c03d
U2 - 10.1016/j.waojou.2024.100914
DO - 10.1016/j.waojou.2024.100914
M3 - Article
C2 - 38855082
SN - 1939-4551
VL - 17
SP - 100914
JO - World Allergy Organization Journal
JF - World Allergy Organization Journal
IS - 6
M1 - 100914
ER -